Online medicine sales crackdown begins—DRAP flags hidden public health threat

ISLAMABAD: What appears as a convenient click-to-buy option may, in reality, be a silent public health threat.

Pakistan’s drug regulator has sounded the alarm over the rapidly expanding illegal online market for medicines, warning that thousands may be unknowingly exposing themselves to dangerous, unverified drugs sold through websites and social media platforms.

In a decisive move, the Drug Regulatory Authority of Pakistan (DRAP) has initiated a nationwide crackdown, formally requesting the Pakistan Telecommunication Authority (PTA) to block digital platforms involved in the unauthorized sale and promotion of pharmaceutical products.

But this is not just about regulation—it is about risk, safety, and a growing digital health crisis.

A digital marketplace with real-world consequences

According to DRAP’s findings, multiple online platforms are actively selling unregistered and smuggled medicines, some reportedly originating from India and Iran.

These are not minor regulatory violations.

Health officials describe this trend as a significant and escalating threat to public health, where medicines bypass all safety checks, quality controls, and legal oversight before reaching consumers.

The concern deepens further when these drugs are marketed directly to vulnerable populations without medical supervision.

The rise of self-medication culture

One of the most troubling aspects highlighted by DRAP is the aggressive online promotion of prescription drugs without authorization.

Medicines related to sexual health, weight loss, and mental health are increasingly being advertised and sold freely across digital platforms.

This, officials warn, is fueling a dangerous culture of self-medication, where individuals diagnose and treat themselves without professional guidance—often with serious consequences.

From adverse drug reactions to delayed diagnosis of underlying conditions, the risks extend far beyond individual patients.

What regulators are doing now

DRAP has made it clear: this is no longer tolerable.

The authority has:

• Requested PTA to block identified websites and social media pages
• Initiated efforts to trace and identify operators behind illegal sales
• Emphasized that prior approval is mandatory for all pharmaceutical advertisements

Violations, officials say, will result in:
• Legal action
• Confiscation of products
• Financial penalties

In parallel, DRAP has urged stronger coordination with digital platforms to ensure rapid removal of illegal drug advertisements.

A warning to the public

While enforcement actions are underway, regulators stress that public awareness is the first line of defense.

Consumers are being strongly advised to:
• Avoid purchasing medicines from unverified online sources
• Ensure pharmacies are licensed and regulated
• Seek qualified medical advice before using any medication

Because in the absence of regulation, what looks like a simple online purchase could lead to serious side effects—or even life-threatening outcomes.

A system under pressure

This crackdown highlights a broader and more complex issue:
Healthcare is rapidly moving online—but regulation is struggling to keep up.

As digital platforms continue to reshape access to medicines, the challenge for authorities is not just enforcement, but building a system that protects patients without restricting access to legitimate care.

For now, DRAP’s message is unambiguous:

Convenience cannot come at the cost of safety.

And the next phase of this crackdown may determine just how deep this problem really goes.

---

Stay informed, stay alert

CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for real-time health alerts, expert insights, and breakthrough medical discoveries.